Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

Literature DB >> 18840741

Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

Blanca I Restrepo¹, Susan P Fisher-Hoch, Brian Smith, Sangchoon Jeon, Mohammad H Rahbar, Joseph B McCormick.

Abstract

Although type 2 diabetes (DM) is a recognized risk factor for development of tuberculosis (TB), the impact on treatment is unclear. Among the few published reports, some suggest that mycobacterial clearance during treatment is delayed in TB patients with DM. Using survival analysis on data from 469 culture-positive TB patients retrospectively identified in south Texas, we found DM to be an independent risk factor for a 5-day delay in mycobacterial clearance within the first 60 days of treatment.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2008 PMID： 18840741 PMCID： PMC3638903

Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345

23 in total

1. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.

Authors: Hanneke M J Nijland; Rovina Ruslami; Janneke E Stalenhoef; Erni J Nelwan; Bachti Alisjahbana; Ron H H Nelwan; Andre J A M van der Ven; Halim Danusantoso; Rob E Aarnoutse; Reinout van Crevel
Journal: Clin Infect Dis Date: 2006-08-22 Impact factor: 9.079

2. Genetic factors in type 2 diabetes: the end of the beginning?

Authors: Stephen O'Rahilly; Inês Barroso; Nicholas J Wareham
Journal: Science Date: 2005-01-21 Impact factor: 47.728

3. Global epidemiology of tuberculosis.

Authors: Christopher Dye
Journal: Lancet Date: 2006-03-18 Impact factor: 79.321

4. Factors changing the manifestation of pulmonary tuberculosis.

Authors: J Y Wang; L N Lee; P R Hsueh
Journal: Int J Tuberc Lung Dis Date: 2005-07 Impact factor: 2.373

5. Diabetes mellitus is strongly associated with tuberculosis in Indonesia.

Authors: B Alisjahbana; R van Crevel; E Sahiratmadja; M den Heijer; A Maya; E Istriana; H Danusantoso; T H M Ottenhoff; R H H Nelwan; J W M van der Meer
Journal: Int J Tuberc Lung Dis Date: 2006-06 Impact factor: 2.373

6. Risk factors for pulmonary tuberculosis in Russia: case-control study.

Authors: Richard Coker; Martin McKee; Rifat Atun; Boika Dimitrova; Ekaterina Dodonova; Sergei Kuznetsov; Francis Drobniewski
Journal: BMJ Date: 2005-12-08

7. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis.

Authors: M Güler; E Unsal; B Dursun; O Aydln; N Capan
Journal: Int J Clin Pract Date: 2007-02 Impact factor: 2.503

8. Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM.

Authors: A B Cantor; J P Krischer; D D Cuthbertson; D A Schatz; W J Riley; J Malone; S Schwartz; T Quattrin; N K Maclaren
Journal: J Clin Endocrinol Metab Date: 1995-12 Impact factor: 5.958

9. An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study.

Authors: N Shetty; M Shemko; M Vaz; G D'Souza
Journal: Int J Tuberc Lung Dis Date: 2006-01 Impact factor: 2.373

10. Clinical investigation of cavitary tuberculosis and tuberculous pneumonia.

Authors: Ki Man Lee; Kang Hyeon Choe; Sung Jin Kim
Journal: Korean J Intern Med Date: 2006-12 Impact factor: 2.884

30 in total

1. Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Authors: Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher
Journal: Tuberculosis (Edinb) Date: 2018-08-18 Impact factor: 3.131

Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

1. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.

2. Genetic factors in type 2 diabetes: the end of the beginning?

3. Global epidemiology of tuberculosis.

4. Factors changing the manifestation of pulmonary tuberculosis.

5. Diabetes mellitus is strongly associated with tuberculosis in Indonesia.

6. Risk factors for pulmonary tuberculosis in Russia: case-control study.

7. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis.

8. Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM.

9. An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study.

10. Clinical investigation of cavitary tuberculosis and tuberculous pneumonia.

1. Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Review 2. Tuberculosis and diabetes mellitus: convergence of two epidemics.

3. Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

4. Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in South India.

5. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.

6. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.

7. The effect of diabetic control status on the clinical features of pulmonary tuberculosis.

Review 8. The re-emerging association between tuberculosis and diabetes: Lessons from past centuries.

9. Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity.

10. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.